DWSSWVYRDPQT peptide identified in this study reportedly targets colon cancer cells in vitro with in silico analysis suggesting the peptide targets glypican-3 (a heparin sulphate proteoglycan (HSPG)) [47]. Here, GPC3 is linked to colonic neoplasm.